Ramis Gheith, MD
Interventional Pain Medicine · Bridgeton, MONPI 1063611895
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Zavation Medical Products, LLC at 37.7% of the total. Among interventional pain medicine clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 330 payments — averaging $220.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zavation Medical Products, LLC$27K
- Vertos Medical, Inc.$17K
- Boston Scientific$5K
- Corelink, LLC$5K
- Nevro Corp.$3K
- Vertiflex, Inc.$2K
- plus $13K from 27 others
What the payments were for
- Consulting fees$37,73252%
- Speaking & faculty fees$7,20010%
- Travel & lodging$11,24015%
- Food & beverage$16,38822%
- Education$510%
- Entertainment$2650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zavation Medical Products, LLC | 33 | $27,472 |
| Vertos Medical, Inc. | 18 | $16,603 |
| Boston Scientific | 13 | $5,317 |
| Corelink, LLC | 10 | $4,959 |
| Nevro Corp. | 49 | $3,484 |
| Vertiflex, Inc. | 10 | $2,425 |
| Abbott | 101 | $2,405 |
| Spinal Simplicity, LLC | 7 | $2,175 |
| Globus Medical | 15 | $1,356 |
| Xtant Medical Inc | 2 | $1,062 |
| Medtronic(2 entities) | 18 | $1,051 |
| Relievant Medsystems, Inc. | 6 | $838 |
| Flowonix Medical Incorporated | 2 | $805 |
| Foundation Fusion Solutions, LLC | 7 | $676 |
| Saluda Medical Americas, Inc. | 9 | $430 |
| Si-bone, Inc. | 2 | $310 |
| Merit Medical Systems Inc | 2 | $237 |
| Tersera Therapeutics LLC | 6 | $217 |
| Stimwave Technologies Incorporated | 1 | $180 |
| Nalu Medical, Inc. | 2 | $159 |
| Curonix LLC | 2 | $121 |
| Painteq LLC | 1 | $113 |
| Axogen | 1 | $108 |
| SPR Therapeutics, Inc | 1 | $103 |
| KCI USA, Inc. | 1 | $66 |
| Averitas Pharma Inc. | 3 | $61 |
| Johnson & Johnson | 2 | $37 |
| Biotronik NRO, Inc. | 1 | $34 |
| Vertex | 1 | $18 |
| Assertio Therapeutics, Inc. | 1 | $17 |
| Bioventus LLC | 1 | $14 |
| Sentynl Therapeutics, Inc. | 1 | $13 |
| Collegium Pharmaceutical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$16,230
- SPECTRA WAVEWRITER$4,894
- HA MINUTEMAN G3-R$2,158
- Superion ISS$2,115
- Omnia$1,623
- Senza$1,536
- Prometra II$805
- Intracept$707
- PROCLAIM$581
- Senza Spinal Cord Stimulation System$427
- Proclaim Family of SCS IPGs$357
- Proclaim IPG$354
- STAR Tumor Ablation System$237
- CORRIDOR$145
- Nalu Neurostimulation System$135
- Evoke$127
- PRIALT$124
- StabiliT$121
- StabiliT System$116
- PAINTEQ$113
How this compares
$72,876 in reported general payments places this provider in the 95th percentile of 27 interventional pain medicine providers in Missouri.
See all interventional pain medicine providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 773 | $16,671 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 501 | $10,535 |
| Buprenorphine | 26 | $8,272 |
| Naloxone Hcl | 105 | $6,206 |
| Gabapentin | 458 | $4,881 |
| BelbucaBuprenorphine Hcl | 11 | $4,526 |
| Tizanidine Hcl | 199 | $2,701 |
| Celecoxib | 137 | $1,950 |
| Diclofenac Sodium | 20 | $1,847 |
| Baclofen | 79 | $1,375 |
| Cephalexin | 119 | $1,128 |
| Duloxetine Hcl | 47 | $906 |
| Pregabalin | 47 | $777 |
| Methylprednisolone | 96 | $600 |
| Tramadol Hcl | 87 | $490 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $12 | $4,52611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 27 interventional pain medicine providers in Missouri.
Other interventional pain medicine in Bridgeton
- Christian OliverBridgeton$18K
- Rebecca SandersJoplin$209K
- Helen BlakeChesterfield$48K
- Andrew FrazierKansas City$32K
- David TonkinSpringfield$14K
- Dwayne JonesKansas City$11K
- Bradford NobleColumbia$8K
- Calvin CajigalDes Peres$8K
- James NewtonColumbia$7K
- Ihab DossWarrensburg$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.